Silence Therapeutics plc - 8-K Filing
Silence Therapeutics agreed to a $6.67 per share buyout by Merck KGaA via a UK scheme of arrangement. (Items: 1.01 Entry into a Material Definitive Agreement, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)